Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...
PARIS, Feb 26 (Reuters) - Sanofi-Aventis has won U.S. approval to market its Apidra Solostar injection pen which contains insulin to treat diabetes, the world's third-biggest drugmaker said on ...
BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
Sanofi-aventis has won FDA approval for Apidra SoloSTAR, a prefilled disposable pen, for children with type 1 diabetes and adults with type 1 or 2 diabetes. Apidra, which has been on the market in the ...
BRIDGEWATER, N.J. A disposable insulin pen for patients ages 4 and older with Type 1 diabetes and adults with Type 2 diabetes has become available in the United States. Sanofi-Aventis U.S. announced ...
Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...
The letter also says Sanofi expects to return to normal supply levels by the first quarter of next year. In the meantime, the company recommends that doctors consider switching patients to Apidra ...
The FDA has approved Apidra SoloSTAR (insulin glulisine[rDNA origin] injection, from sanofi-aventis), a prefilled disposable pencontaining Apidra. Apidra SoloSTAR makes administration of insulin ...
March 3, 2009 — On February 26, sanofi-aventis announced that a prefilled disposable pen containing insulin glulisine (Apidra SoloSTAR) was approved by the US Food and Drug Administration (FDA). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results